Cargando…

Factors that influence clinicians’ decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study

OBJECTIVE: Little is known about clinicians’ decision-making about decreasing active surveillance (AS) testing/converting patients to watchful waiting (WW), nor are there any guidelines. The objective of this study was to identify factors that clinicians consider when decreasing AS testing/convertin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lowenstein, Lisa M, Choi, Noah J, Hoffman, Karen E, Volk, Robert J, Loeb, Stacy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593754/
https://www.ncbi.nlm.nih.gov/pubmed/34772748
http://dx.doi.org/10.1136/bmjopen-2020-048347
_version_ 1784599820761038848
author Lowenstein, Lisa M
Choi, Noah J
Hoffman, Karen E
Volk, Robert J
Loeb, Stacy
author_facet Lowenstein, Lisa M
Choi, Noah J
Hoffman, Karen E
Volk, Robert J
Loeb, Stacy
author_sort Lowenstein, Lisa M
collection PubMed
description OBJECTIVE: Little is known about clinicians’ decision-making about decreasing active surveillance (AS) testing/converting patients to watchful waiting (WW), nor are there any guidelines. The objective of this study was to identify factors that clinicians consider when decreasing AS testing/converting to WW for men with prostate cancer. DESIGN: Exploratory qualitative study. SETTING: All participants practiced in various institutions in the USA. PARTICIPANTS: Eligible clinicians had to provide clinical care for patients with prostate cancer in the USA and speak English. Clinicians could be either urologists or radiation oncologists. Of the 24 clinicians, 83% were urologists representing 11 states, 92% were men and 62% were white. METHODS: This qualitative study used data from semi-structured interviews. Purposive sampling was used to ensure geographical variation in the USA. Data collection continued until thematic saturation was achieved. Framework analysis guided coding and identification of themes. Two researchers coded all transcripts independently, met to discuss and reached consensus. RESULTS: Interviews with clinicians demonstrated that testing or monitoring for AS or transitioning to WW is happening in practice, whether intentionally or unintentionally. Decisions to decrease AS were personalised and tailored to patients’ health status. Life expectancy was the dominant factor that influenced decision, but clinicians were generally hesitant to specify an age when they would decrease AS or transition to WW. Fear that poor adherence could lead to missed progression and concerns about the medico-legal issue of not doing enough were cited as barriers to decreasing AS. CONCLUSIONS: These findings suggest that in certain situations, AS frequency is reduced or transitioned to WW, yet decisions appear to be inconsistent and there are no significant barriers. These findings could inform further areas to explore when drafting recommendations that consider patients’ values and preferences when making decisions about decreasing AS/converting to WW.
format Online
Article
Text
id pubmed-8593754
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-85937542021-11-24 Factors that influence clinicians’ decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study Lowenstein, Lisa M Choi, Noah J Hoffman, Karen E Volk, Robert J Loeb, Stacy BMJ Open Health Services Research OBJECTIVE: Little is known about clinicians’ decision-making about decreasing active surveillance (AS) testing/converting patients to watchful waiting (WW), nor are there any guidelines. The objective of this study was to identify factors that clinicians consider when decreasing AS testing/converting to WW for men with prostate cancer. DESIGN: Exploratory qualitative study. SETTING: All participants practiced in various institutions in the USA. PARTICIPANTS: Eligible clinicians had to provide clinical care for patients with prostate cancer in the USA and speak English. Clinicians could be either urologists or radiation oncologists. Of the 24 clinicians, 83% were urologists representing 11 states, 92% were men and 62% were white. METHODS: This qualitative study used data from semi-structured interviews. Purposive sampling was used to ensure geographical variation in the USA. Data collection continued until thematic saturation was achieved. Framework analysis guided coding and identification of themes. Two researchers coded all transcripts independently, met to discuss and reached consensus. RESULTS: Interviews with clinicians demonstrated that testing or monitoring for AS or transitioning to WW is happening in practice, whether intentionally or unintentionally. Decisions to decrease AS were personalised and tailored to patients’ health status. Life expectancy was the dominant factor that influenced decision, but clinicians were generally hesitant to specify an age when they would decrease AS or transition to WW. Fear that poor adherence could lead to missed progression and concerns about the medico-legal issue of not doing enough were cited as barriers to decreasing AS. CONCLUSIONS: These findings suggest that in certain situations, AS frequency is reduced or transitioned to WW, yet decisions appear to be inconsistent and there are no significant barriers. These findings could inform further areas to explore when drafting recommendations that consider patients’ values and preferences when making decisions about decreasing AS/converting to WW. BMJ Publishing Group 2021-11-12 /pmc/articles/PMC8593754/ /pubmed/34772748 http://dx.doi.org/10.1136/bmjopen-2020-048347 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Health Services Research
Lowenstein, Lisa M
Choi, Noah J
Hoffman, Karen E
Volk, Robert J
Loeb, Stacy
Factors that influence clinicians’ decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study
title Factors that influence clinicians’ decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study
title_full Factors that influence clinicians’ decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study
title_fullStr Factors that influence clinicians’ decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study
title_full_unstemmed Factors that influence clinicians’ decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study
title_short Factors that influence clinicians’ decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study
title_sort factors that influence clinicians’ decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study
topic Health Services Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593754/
https://www.ncbi.nlm.nih.gov/pubmed/34772748
http://dx.doi.org/10.1136/bmjopen-2020-048347
work_keys_str_mv AT lowensteinlisam factorsthatinfluencecliniciansdecisionstodecreaseactivesurveillancemonitoringfrequencyortransitiontowatchfulwaitingforlocalisedprostatecanceraqualitativestudy
AT choinoahj factorsthatinfluencecliniciansdecisionstodecreaseactivesurveillancemonitoringfrequencyortransitiontowatchfulwaitingforlocalisedprostatecanceraqualitativestudy
AT hoffmankarene factorsthatinfluencecliniciansdecisionstodecreaseactivesurveillancemonitoringfrequencyortransitiontowatchfulwaitingforlocalisedprostatecanceraqualitativestudy
AT volkrobertj factorsthatinfluencecliniciansdecisionstodecreaseactivesurveillancemonitoringfrequencyortransitiontowatchfulwaitingforlocalisedprostatecanceraqualitativestudy
AT loebstacy factorsthatinfluencecliniciansdecisionstodecreaseactivesurveillancemonitoringfrequencyortransitiontowatchfulwaitingforlocalisedprostatecanceraqualitativestudy